AAV2-hRPE65v2,voretigene neparvovec-rzyl

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AAV2-hRPE65v2,voretigene neparvovec-rzyl
Treatment and conditionWhere it standsTrials
AAV2-hRPE65v2,voretigene neparvovec-rzyl for leber congenital amaurosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AAV2-hRPE65v2,voretigene neparvovec-rzyl for retinitis pigmentosaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1